Commodore Capital Investor

Commodore Capital is invested in the early stages of a major innovation cycle in biopharmaceuticals.
Technology: Cell_Therapies
Industry: Longevity Industry 2022
Headquarters: New York, New York, United States
Founded Date: 2019-01-01
Employees Number: 1-10
Investor Type: Venture Capital
Investment Stage: Early Stage Venture
Number Of Exits: 12
Acquisitions Number: 5

Visit Website
info@commodorecapital.com
Register and Claim Ownership